ARGUN AKCAKANAT to Molecular Targeted Therapy
This is a "connection" page, showing publications ARGUN AKCAKANAT has written about Molecular Targeted Therapy.
Connection Strength
0.068
-
Targeting the PI3-kinase/Akt/mTOR signaling pathway. Surg Oncol Clin N Am. 2013 Oct; 22(4):641-64.
Score: 0.053
-
Catalytic mTOR inhibitors can overcome intrinsic and acquired resistance to allosteric mTOR inhibitors. Oncotarget. 2014 Sep 30; 5(18):8544-57.
Score: 0.014